Vor Biopharma Inc Cash Flow-to-Debt Ratio
Vor Biopharma Inc cash flow-to-debt ratio. Vor Biopharma Inc (VOR) has a Cash Flow-to-Debt Ratio of -0.04x as of June 2026, meaning its operating cash flow of $-25.67 Million could theoretically repay 0% of its total liabilities ($681.25 Million) in one year. Check Vor Biopharma Inc (VOR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vor Biopharma Inc (2018–2025)
Cash flow-to-debt ratio of Vor Biopharma Inc from 2018 to 2025. Historical debt coverage capacity for Vor Biopharma Inc across 8 annual periods. Also explore Vor Biopharma Inc equity growth rate to track the company's year-over-year net asset growth rate.
Vor Biopharma Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Vor Biopharma Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Vor Biopharma Inc. For the full cash flow conversion analysis, see Vor Biopharma Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.23x | $-142.71 Million | $628.44 Million | ▲ +89.5% |
| 2024 | -2.16x | $-99.66 Million | $46.23 Million | ▼ -27.1% |
| 2023 | -1.70x | $-100.29 Million | $59.10 Million | ▲ +2.8% |
| 2022 | -1.75x | $-85.14 Million | $48.76 Million | ▲ +33.5% |
| 2021 | -2.63x | $-69.14 Million | $26.33 Million | ▼ -100.0% |
| 2020 | -1.31x | $-36.29 Million | $27.64 Million | ▲ +70.9% |
| 2019 | -4.51x | $-9.86 Million | $2.19 Million | ▼ -1217.1% |
| 2018 | -0.34x | $-2.66 Million | $7.77 Million | — |